发明名称 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
摘要 The present invention provides methods for the treatment or porphylaxis of one or more aldosterone-mediated pathogenic effects in a subject suffering from or susceptible to the pathogenic effect or effects wherein the subject has one or more conditions selected from the group consisting of a sub-normal endogenous aldosterone level, salt sensitivity and an elevated dietary sodium intake. The methods comprise administering to the subject a therapeutically-effective amount of one or more epoxy-steroidal compounds that are aldosterone antagonists.
申请公布号 AU1604001(A) 申请公布日期 2001.12.24
申请号 AU20010016040 申请日期 2000.11.01
申请人 PHARMACIA CORPORATION 发明人 GORDON H. WILLIAMS;JOHN W. FUNDER;SUSAN M. GARTHWAITE;BARBARA RONIKER;KENTON N. FEDDE;RICARDO ROCHA
分类号 A61K45/00;A61K31/00;A61K31/415;A61K31/4152;A61K31/437;A61K31/5513;A61K31/56;A61K31/57;A61K31/58;A61K31/585;A61K45/06;A61P1/16;A61P3/10;A61P7/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P13/12;A61P15/08;A61P25/00;A61P25/06;A61P27/02;A61P43/00;C07J9/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址